On the other hand, in liver tumors, both in HCC and cholangiocarcinoma (CCA), many SLC22A1 genetic variants have been found, both SNVs and aberrant splicing forms, which result in reduced or even abolished transporter function, when truncated proteins are generated[83]. Here, SLC22A1 is linked to cholangiocarcinoma.